Literature DB >> 32443123

CE: Opioid Use Disorder: Pathophysiology, Assessment, and Effective Interventions.

Kate Garland Brown1, Bernadette Capili.   

Abstract

Opioid use disorder (OUD) is a chronic, relapsing disease. Genetic variability, dysregulated stress system response, and history of opioid experimentation or escalating exposure all contribute to the likelihood of developing OUD, which produces complex brain changes that make it difficult to stop opioid use. Understanding the neurobiology of OUD helps nurses anticipate the behaviors of patients with OUD and approach them with empathy. Here, the authors discuss the pathophysiology of OUD, available screening tools, medical treatments, and behavioral interventions that have demonstrated efficacy in reducing substance use.

Entities:  

Mesh:

Year:  2020        PMID: 32443123      PMCID: PMC7446957          DOI: 10.1097/01.NAJ.0000668736.80609.4e

Source DB:  PubMed          Journal:  Am J Nurs        ISSN: 0002-936X            Impact factor:   2.577


  19 in total

1.  Keeping patients safe from methadone overdoses.

Authors:  Matthew Grissinger
Journal:  P T       Date:  2011-08

Review 2.  Management of opioid use disorder in the USA: present status and future directions.

Authors:  Carlos Blanco; Nora D Volkow
Journal:  Lancet       Date:  2019-03-14       Impact factor: 79.321

Review 3.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation.

Authors:  G P Chrousos
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

4.  Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.

Authors:  Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2013-02-12       Impact factor: 4.492

Review 5.  DSM-5 criteria for substance use disorders: recommendations and rationale.

Authors:  Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2013-08       Impact factor: 18.112

Review 6.  Molecular mechanisms of opioid receptor-dependent signaling and behavior.

Authors:  Ream Al-Hasani; Michael R Bruchas
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

Review 7.  Central and Peripheral Biomarkers of Stress Response for Addiction Risk and Relapse Vulnerability.

Authors:  Verica Milivojevic; Rajita Sinha
Journal:  Trends Mol Med       Date:  2018-01-25       Impact factor: 11.951

8.  The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013.

Authors:  Curtis S Florence; Chao Zhou; Feijun Luo; Likang Xu
Journal:  Med Care       Date:  2016-10       Impact factor: 2.983

9.  ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans.

Authors:  M J Kreek; J Ragunath; S Plevy; D Hamer; B Schneider; N Hartman
Journal:  Neuropeptides       Date:  1984-12       Impact factor: 3.286

10.  A multistep general theory of transition to addiction.

Authors:  Pier Vincenzo Piazza; Véronique Deroche-Gamonet
Journal:  Psychopharmacology (Berl)       Date:  2013-08-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.